肛門疾患治療の世界市場レポート 2025年

肛門疾患治療市場規模は、今後数年間で力強い成長が見込まれます。2029年には57億7,000万米ドルに成長し、CAGRは6.5%となります。予測期間の成長は、患者教育需要、食生活の変化、遠隔医療需要、研究開発活動に起因します。予測期間の主な動向には、技術の進歩、内視鏡検査と画像処理、公衆衛生への取り組みなどがあります。

高齢者人口の増加が、当面の肛門疾患治療市場の拡大を牽引すると予測されます。この層は高齢者を構成し、通常65歳以上の個人と定義されます。肛門障害治療は、肛門障害に悩む高齢者層に対して、痛みの緩和、衛生状態の改善、再発防止、全体的な生活の質の向上を提供する上で重要な役割を果たしています。例えば、2022年10月、米国に本部を置く保健専門機関である世界保健機関（WHO）は、世界全体では2030年までに6人に1人が60歳以上になると報告し、この数は2050年までに21億人の高齢者に達すると予測しています。その結果、高齢者人口の増加が肛門疾患治療市場成長の重要な促進要因となっています。

大腸がん患者の急増は、当面の肛門疾患治療市場の成長を牽引すると予測されます。結腸または直腸に発生する悪性腫瘍である大腸がんは、肛門障害治療の焦点です。この治療は、がんやその治療に起因する痛み、瘻孔、腸の不調などの症状を緩和し、最終的に患者の快適さと生活の質を高めることを目的としています。例えば、2023年5月現在、米国を拠点とする著名な専門機関である米国臨床腫瘍学会は、米国の成人約153,020人が大腸がんの診断を受けると推定しています。この数字には結腸がんの106,970例と直腸がんの46,050例が含まれます。その結果、大腸がんの発生率の上昇が肛門疾患治療市場拡大の原動力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界肛門疾患治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の肛門疾患治療市場：成長率分析
• 世界の肛門疾患治療市場の実績：規模と成長, 2019-2024
• 世界の肛門疾患治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界肛門疾患治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の肛門疾患治療市場治療別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 薬物
• 手術
• その他の治療
• 世界の肛門疾患治療市場：疾患別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 下痢
• 痔核
• 膿瘍
• 瘻孔
• かゆみ
• その他の病気
• 世界の肛門疾患治療市場、セグメンテーション投与経路、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• 非経口
• 直腸
• その他の投与経路
• 世界の肛門疾患治療市場、エンドユーザーのタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 専門クリニック
• その他のエンドユーザー
• 世界の肛門疾患治療市場、薬物の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 外用剤
• 経口薬
• 直腸坐薬
• 世界の肛門疾患治療市場、手術の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• 痔核切除術
• 瘻孔切開術
• 括約筋切開術
• その他の外科手術
• 世界の肛門疾患治療市場、その他の治療のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ライフスタイルの変更
• 食生活の変化
• 理学療法
• 低侵襲手術

第7章 地域別・国別分析

• 世界の肛門疾患治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の肛門疾患治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 肛門疾患治療市場：競合情勢
• 肛門疾患治療市場：企業プロファイル
  • Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Cigna Corporation. Overview, Products and Services, Strategy and Financial Analysis
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Novartis AG
• AstraZeneca Plc
• Merck and Co. Inc.
• Abbott Laboratories
• GlaxoSmithKline Plc
• Medtronic Plc
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Company
• McKesson Corporation
• Teva Pharmaceutical Industries Ltd.
• Boston Scientific Corporation
• Mylan N.V.
• B. Braun Melsungen AG
• Bausch Health Companies Inc.
• Olympus Corporation

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 肛門疾患治療市場2029：新たな機会を提供する国
• 肛門疾患治療市場2029：新たな機会を提供するセグメント
• 肛門疾患治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Anorectal disorder treatment involves addressing a set of medical conditions that impact the anal and rectal areas, leading to the development of anorectal disorders. The nature and severity of these disorders may vary depending on the specific condition.

The primary approaches to anorectal disorder treatment include medications, surgical procedures, and other therapeutic methods. Medications are substances employed for diagnosing, managing, preventing, or alleviating a range of medical conditions and ailments. These conditions encompass diarrhea, hemorrhoids, abscesses, fistulas, itching, among others. Medications can be administered through oral, parenteral, rectal, or other routes. These treatment modalities are utilized by diverse end-users, including hospitals, specialty clinics, and other healthcare facilities.

The anorectal disorders treatment market research report is one of a series of new reports from The Business Research Company that provides anorectal disorders treatment market statistics, including anorectal disorders treatment industry global market size, regional shares, competitors with anorectal disorders treatment market share, detailed anorectal disorders treatment market segments, market trends and opportunities and any further data you may need to thrive in the anorectal disorders treatment industry. This anorectal disorders treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The anorectal disorders treatment market size has grown strongly in recent years. It will grow from $4.2 billion in 2024 to $4.49 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to aging population, lifestyle factors, increased awareness, on-surgical interventions.

The anorectal disorders treatment market size is expected to see strong growth in the next few years. It will grow to $5.77 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to demand for patient education, changing dietary habits, demand for telemedicine, research and development activities. Major trends in the forecast period include technological advancements, endoscopy and imaging, public health initiatives.

The increasing elderly population is anticipated to drive the expansion of the anorectal disorder treatment market in the foreseeable future. This demographic constitutes older adults, typically defined as individuals aged 65 or above. Anorectal disorder treatment plays a crucial role in offering pain relief, improving hygiene, preventing recurrence, and enhancing the overall quality of life for the elderly population afflicted with anorectal disorders. For instance, in October 2022, the World Health Organization, a specialized health agency based in the US, reported that globally, one out of every six individuals would be 60 years or older by 2030, and this number is projected to reach 2.1 billion elderly people by 2050. Consequently, the escalating geriatric population is a significant driver behind the growth of the anorectal disorder treatment market.

The surge in colorectal cancer cases is projected to drive the growth of the anorectal disorder treatment market in the foreseeable future. Colorectal cancer, a malignancy originating in the colon or rectum, is the focal point of anorectal disorder treatment. This treatment aims to alleviate symptoms like pain, fistulas, and bowel irregularities resulting from the cancer or its treatment, ultimately enhancing patient comfort and quality of life. For instance, as of May 2023, the American Society of Clinical Oncology, a reputable US-based professional organization, estimates that approximately 153,020 adults in the US will receive a colorectal cancer diagnosis. This figure includes 106,970 new cases of colon cancer and 46,050 new cases of rectal cancer. Consequently, the escalating incidence of colorectal cancer is a driving force behind the expansion of the anorectal disorder treatment market.

Prominent companies in the anorectal disorder treatment market are introducing novel medications and securing approvals to strengthen their market presence. This surge in drug development is broadening the spectrum of treatment options available for anorectal disorders, offering patients more precise and efficacious treatment choices, exemplified by the introduction of Budesonide 2mg Rectal Foam. For instance, in April 2023, Padagis US LLC, a reputable US-based pharmaceutical manufacturer, unveiled Budesonide 2mg Rectal Foam (a generic version of Uceris), an FDA-approved treatment for anorectal disorders. Uceris is a prescription corticosteroid medication utilized to manage active, mild-to-moderate cases of ulcerative colitis, an inflammatory bowel disease (IBD) that primarily affects the rectum and extends from the rectum to the sigmoid colon.

In June 2023, Merck and Co. Inc., a prominent US-based pharmaceutical company, completed the acquisition of Prometheus Biosciences Inc. for a sum of $10.8 billion. This strategic move is set to fortify Merck's immunology pipeline and bolster its presence in the field of immune-mediated diseases. Prometheus Biosciences Inc. is a distinguished biotechnology company based in the US, specializing in the development of products and treatments for inflammatory bowel disease, which encompasses anorectal disorders.

Major companies operating in the anorectal disorders treatment market are Cardinal Health Inc., Cigna Corporation., Pfizer Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Novartis AG, AstraZeneca PLC, Merck and Co. Inc., Abbott Laboratories, GlaxoSmithKline PLC, Medtronic PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, McKesson Corporation, Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, Mylan N.V., B. Braun Melsungen AG, Bausch Health Companies Inc., Olympus Corporation, Sun Pharmaceutical Industries Ltd., Ethicon Inc., Coloplast A/S, Teleflex Incorporated, Cook Medical Inc., ConvaTec Group PLC, Lupin Limited, Akorn Inc., NATCO Pharma Limited.

North America was the largest region in the anorectal disorders treatment market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in anorectal disorders treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the anorectal disorders treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The anorectal disorders treatment market consists of revenues earned by entities by providing medical consultation, diagnostic tests and surgeries. The market value includes the value of related goods sold by the service provider or included within the service offering. The anorectal disorder treatment market also consists of sales of topical creams and ointments, wipes and cleansers and pads. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Anorectal Disorders Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on anorectal disorders treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for anorectal disorders treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The anorectal disorders treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment: Drugs; Surgery; Other Treatment
• 2) By Disease: Diarrhea; Hemorrhoid; Abscesse; Fistula; Itching; Other Disease
• 3) By Route Of Administration: Oral; Parenteral; Rectal; Other Route of administration
• 4) By End-Users: Hospitals; Specialty Clinics; Other End-Users
• Subsegments:
• 1) By Drugs: Topical Agents; Oral Medications; Rectal Suppositories
• 2) By Surgery: Hemorrhoidectomy; Fistulotomy; Sphincterotomy; Other Surgical Procedures
• 3) By Other Treatment: Lifestyle Modifications; Dietary Changes; Physical Therapy; Minimally Invasive Procedures
• Companies Mentioned: Cardinal Health Inc.; Cigna Corporation.; Pfizer Inc.; F. Hoffmann-La Roche Ltd.; AbbVie Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Anorectal Disorders Treatment Market Characteristics

3. Anorectal Disorders Treatment Market Trends And Strategies

4. Anorectal Disorders Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Anorectal Disorders Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Anorectal Disorders Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Anorectal Disorders Treatment Market Growth Rate Analysis
• 5.4. Global Anorectal Disorders Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Anorectal Disorders Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Anorectal Disorders Treatment Total Addressable Market (TAM)

6. Anorectal Disorders Treatment Market Segmentation

• 6.1. Global Anorectal Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drugs
• Surgery
• Other Treatment
• 6.2. Global Anorectal Disorders Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diarrhea
• Hemorrhoid
• Abscesse
• Fistula
• Itching
• Other Disease
• 6.3. Global Anorectal Disorders Treatment Market, Segmentation Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Parenteral
• Rectal
• Other Route of administration
• 6.4. Global Anorectal Disorders Treatment Market, Sub-Segmentation Of End-Users, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Other End-Users
• 6.5. Global Anorectal Disorders Treatment Market, Sub-Segmentation Of Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical Agents
• Oral Medications
• Rectal Suppositories
• 6.6. Global Anorectal Disorders Treatment Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hemorrhoidectomy
• Fistulotomy
• Sphincterotomy
• Other Surgical Procedures
• 6.7. Global Anorectal Disorders Treatment Market, Sub-Segmentation Of Other Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lifestyle Modifications
• Dietary Changes
• Physical Therapy
• Minimally Invasive Procedures

7. Anorectal Disorders Treatment Market Regional And Country Analysis

• 7.1. Global Anorectal Disorders Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Anorectal Disorders Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Anorectal Disorders Treatment Market

• 8.1. Asia-Pacific Anorectal Disorders Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Anorectal Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Anorectal Disorders Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Anorectal Disorders Treatment Market, Segmentation Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Anorectal Disorders Treatment Market

• 9.1. China Anorectal Disorders Treatment Market Overview
• 9.2. China Anorectal Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Anorectal Disorders Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Anorectal Disorders Treatment Market, Segmentation Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Anorectal Disorders Treatment Market

• 10.1. India Anorectal Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Anorectal Disorders Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Anorectal Disorders Treatment Market, Segmentation Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Anorectal Disorders Treatment Market

• 11.1. Japan Anorectal Disorders Treatment Market Overview
• 11.2. Japan Anorectal Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Anorectal Disorders Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Anorectal Disorders Treatment Market, Segmentation Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Anorectal Disorders Treatment Market

• 12.1. Australia Anorectal Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Anorectal Disorders Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Anorectal Disorders Treatment Market, Segmentation Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Anorectal Disorders Treatment Market

• 13.1. Indonesia Anorectal Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Anorectal Disorders Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Anorectal Disorders Treatment Market, Segmentation Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Anorectal Disorders Treatment Market

• 14.1. South Korea Anorectal Disorders Treatment Market Overview
• 14.2. South Korea Anorectal Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Anorectal Disorders Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Anorectal Disorders Treatment Market, Segmentation Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Anorectal Disorders Treatment Market

• 15.1. Western Europe Anorectal Disorders Treatment Market Overview
• 15.2. Western Europe Anorectal Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Anorectal Disorders Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Anorectal Disorders Treatment Market, Segmentation Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Anorectal Disorders Treatment Market

• 16.1. UK Anorectal Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Anorectal Disorders Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Anorectal Disorders Treatment Market, Segmentation Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Anorectal Disorders Treatment Market

• 17.1. Germany Anorectal Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Anorectal Disorders Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Anorectal Disorders Treatment Market, Segmentation Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Anorectal Disorders Treatment Market

• 18.1. France Anorectal Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Anorectal Disorders Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Anorectal Disorders Treatment Market, Segmentation Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Anorectal Disorders Treatment Market

• 19.1. Italy Anorectal Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Anorectal Disorders Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Anorectal Disorders Treatment Market, Segmentation Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Anorectal Disorders Treatment Market

• 20.1. Spain Anorectal Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Anorectal Disorders Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Anorectal Disorders Treatment Market, Segmentation Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Anorectal Disorders Treatment Market

• 21.1. Eastern Europe Anorectal Disorders Treatment Market Overview
• 21.2. Eastern Europe Anorectal Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Anorectal Disorders Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Anorectal Disorders Treatment Market, Segmentation Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Anorectal Disorders Treatment Market

• 22.1. Russia Anorectal Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Anorectal Disorders Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Anorectal Disorders Treatment Market, Segmentation Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Anorectal Disorders Treatment Market

• 23.1. North America Anorectal Disorders Treatment Market Overview
• 23.2. North America Anorectal Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Anorectal Disorders Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Anorectal Disorders Treatment Market, Segmentation Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Anorectal Disorders Treatment Market

• 24.1. USA Anorectal Disorders Treatment Market Overview
• 24.2. USA Anorectal Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Anorectal Disorders Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Anorectal Disorders Treatment Market, Segmentation Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Anorectal Disorders Treatment Market

• 25.1. Canada Anorectal Disorders Treatment Market Overview
• 25.2. Canada Anorectal Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Anorectal Disorders Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Anorectal Disorders Treatment Market, Segmentation Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Anorectal Disorders Treatment Market

• 26.1. South America Anorectal Disorders Treatment Market Overview
• 26.2. South America Anorectal Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Anorectal Disorders Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Anorectal Disorders Treatment Market, Segmentation Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Anorectal Disorders Treatment Market

• 27.1. Brazil Anorectal Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Anorectal Disorders Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Anorectal Disorders Treatment Market, Segmentation Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Anorectal Disorders Treatment Market

• 28.1. Middle East Anorectal Disorders Treatment Market Overview
• 28.2. Middle East Anorectal Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Anorectal Disorders Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Anorectal Disorders Treatment Market, Segmentation Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Anorectal Disorders Treatment Market

• 29.1. Africa Anorectal Disorders Treatment Market Overview
• 29.2. Africa Anorectal Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Anorectal Disorders Treatment Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Anorectal Disorders Treatment Market, Segmentation Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Anorectal Disorders Treatment Market Competitive Landscape And Company Profiles

• 30.1. Anorectal Disorders Treatment Market Competitive Landscape
• 30.2. Anorectal Disorders Treatment Market Company Profiles
  • 30.2.1. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Cigna Corporation. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Anorectal Disorders Treatment Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. AstraZeneca Plc
• 31.3. Merck and Co. Inc.
• 31.4. Abbott Laboratories
• 31.5. GlaxoSmithKline Plc
• 31.6. Medtronic Plc
• 31.7. Takeda Pharmaceutical Company Limited
• 31.8. Eli Lilly and Company
• 31.9. McKesson Corporation
• 31.10. Teva Pharmaceutical Industries Ltd.
• 31.11. Boston Scientific Corporation
• 31.12. Mylan N.V.
• 31.13. B. Braun Melsungen AG
• 31.14. Bausch Health Companies Inc.
• 31.15. Olympus Corporation

32. Global Anorectal Disorders Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Anorectal Disorders Treatment Market

34. Recent Developments In The Anorectal Disorders Treatment Market

35. Anorectal Disorders Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Anorectal Disorders Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Anorectal Disorders Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Anorectal Disorders Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer